The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: In vitro susceptibility of 375 Candida albicans isolates and biofilm production

Anna Maria Tortorano, Anna Prigitano, Emanuela Biraghi, Maria Anna Viviani, A. Astolfi, C. Ossi, S. Perin, C. Bonaccorso, L. Garlaschi, G. Viola, M. Saudelli, S. Frugoni, A. Mauri, R. Passerini, C. Farina, M. Tejada, C. Cavanna, A. Raballo, A. Grossi, C. BezziM. Spinelli, S. Bramati, G. Pinsi, L. Colombo, L. Ferrari, P. Troupioti, G. L. Lombardi, M. Arghittu, C. Agrappi, L. Sturla, G. Gialluca, M. G. Musmanno, A. Ceraminiello, P. Casell, P. Porri, S. Pierdomenico, S. Gualterotti, R. Sala

Research output: Contribution to journalArticle

Abstract

Objectives: To investigate the in vitro antifungal susceptibility pattern of 375 Candida albicans bloodstream isolates recovered during the European Confederation of Medical Mycology survey of candidaemia performed in Lombardia, Italy and to test the ability to form biofilm. Methods: In vitro susceptibility to flucytosine, fluconazole, itraconazole, posaconazole, voriconazole and caspofungin was performed by broth microdilution following the NCCLS guidelines. Biofilm production was measured using the XTT reduction assay in 59 isolates selected as representative of different patterns of susceptibility to flucytosine and azoles. Results: MICs (mg/L) at which 90% of the strains were inhibited were ≤0.25 for flucytosine, 0.25 for caspofungin, 4 for fluconazole and 0.06 for itraconazole, voriconazole and posaconazole. Flucytosine resistance was detected in five isolates and was associated with serotype B in 2/29 and serotype A in 3/346. Resistance to fluconazole was detected in 10 isolates; nine of these exhibited reduced susceptibility to the other azoles. Among the 10 patients with fluconazole-resistant C. albicans bloodstream infection, only one, an AIDS patient, had been previously treated with fluconazole. Biofilm production was observed in 23 isolates (39%) and was significantly associated with serotype B. No relationship was detected with the pattern of antifungal susceptibility. Conclusions: Resistance is uncommon in C. albicans isolates recovered from blood cultures, while biofilm production is a relatively frequent event. Periodic surveillance is warranted to monitor the incidence of in vitro antifungal resistance as well as of biofilm production.

Original languageEnglish
Pages (from-to)777-779
Number of pages3
JournalJournal of Antimicrobial Chemotherapy
Volume56
Issue number4
DOIs
Publication statusPublished - Oct 2005

Keywords

  • Azoles
  • Caspofungin
  • Flucytosine
  • Posaconazole
  • Voriconazole

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology

Fingerprint Dive into the research topics of 'The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: In vitro susceptibility of 375 Candida albicans isolates and biofilm production'. Together they form a unique fingerprint.

  • Cite this

    Tortorano, A. M., Prigitano, A., Biraghi, E., Viviani, M. A., Astolfi, A., Ossi, C., Perin, S., Bonaccorso, C., Garlaschi, L., Viola, G., Saudelli, M., Frugoni, S., Mauri, A., Passerini, R., Farina, C., Tejada, M., Cavanna, C., Raballo, A., Grossi, A., ... Sala, R. (2005). The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: In vitro susceptibility of 375 Candida albicans isolates and biofilm production. Journal of Antimicrobial Chemotherapy, 56(4), 777-779. https://doi.org/10.1093/jac/dki310